Skip to main content
OpenTrials

Clinical trial condition

Diffuse Large B Cell Lymphoma

Explore clinical trials studying Diffuse Large B Cell Lymphoma. Study availability and eligibility vary by location and protocol.

165 public trials 52 recruiting studies
Refine in advanced search Browse all conditions

Diffuse Large B Cell Lymphoma trial results

Completed

Observational Retrospective Cohort Study of Systemic Therapies for R/R DLBCL

NCT04697160

Conditions
Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • MorphoSys Research Site Scottsdale, Arizona, United States
  • MorphoSys Research Site Clovis, California, United States
  • MorphoSys Research Site Los Angeles, California, United States
  • MorphoSys Research Site Orange, California, United States
View all 165 locations
View Trial Details
Completed

Trial of Idelalisib in Patients With Relapsed Diffuse Large B-cell Lymphoma

NCT03576443

Conditions
Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Aarhus University Hospital Aarhus C, Denmark
  • Odense University Hospital Odense, Denmark
  • Halmstad County Hospital Halmstad, Sweden
  • Linkoping University Hospital Linköping, Sweden
View Trial Details
Completed

Efficacy of Lenalidomide in Combination With Subcutaneous Rituximab + miniCHOP in DLBCL Patients of 80 y/o or+

NCT02128061

Conditions
Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • ZNA Stuivenberg Antwerp, Belgium
  • A. Z. Sint-Jan Bruges, Belgium
  • Institut Jules Bordet Brussels, Belgium
  • Université Catholique de Louvain Saint Luc Brussels, Belgium
View all 97 locations
View Trial Details
Completed

To Decrease Fatigue With Light Therapy

NCT03242902

Conditions
Diffuse Large B Cell Lymphoma, Dyssomnias, Hemic and Lymphatic Diseases, +17 more
Locations
  • Radboudumc Nijmegen, Gelderland, Netherlands
  • Netherlands Cancer Institute Amsterdam, North Holland, Netherlands
  • VUmc Amsterdam, North Holland, Netherlands
  • Leids Universitair Medisch Centrum Leiden, South Holland, Netherlands
View Trial Details
Completed

Dose Escalation Study in Patients With Relapsed or Refractory DLBCL and MyD88 L265P Mutation

NCT02252146

Conditions
Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • UCLA Medical Center Los Angeles, California, United States
  • Emory University Atlanta, Georgia, United States
  • Cancer Care Specialists of Illinois Decatur, Illinois, United States
  • Horizon Bio Advance Lafayette, Indiana, United States
View Trial Details

Related conditions